central
nervou
system
cn
consid
uniqu
environ
allow
basal
immun
surveil
physiolog
condit
restrain
potenti
deleteri
inflammatori
reaction
diseas
state
tight
control
traffick
immun
cell
toward
cn
major
paramet
contribut
statu
inde
circul
immun
cell
cross
protect
barrier
use
complex
multistep
cascad
involv
distinct
traffick
cue
surfac
cn
endotheli
cell
immun
cell
current
knowledg
regard
migrat
cn
deriv
mainli
cell
wherea
littl
known
cell
inflammatori
condit
either
due
autoimmun
respons
infect
inflam
barrier
bbb
endothelium
upregul
express
adhes
molecul
selectin
cell
adhes
molecul
immunoglobulin
superfamili
sever
surfac
molecul
express
cell
glycoprotein
regul
sequenti
step
transmigr
includ
tether
roll
captur
firm
adhes
final
diapedesi
circul
cell
across
endotheli
layer
antigen
recognit
subarachnoid
space
allow
cell
migrat
glia
limitan
superficiali
cn
parenchyma
lead
clinic
diseas
scenario
pivot
role
interact
heterodim
express
activ
helper
cell
vascular
cell
adhes
protein
main
ligand
bbb
endotheli
cell
demonstr
howev
cell
shown
infiltr
brain
absenc
manner
rout
cn
exist
crucial
subset
although
cumul
evid
point
key
role
cell
sever
inflammatori
cn
disord
ms
autoimmun
enceph
immun
reconstitut
inflammatori
syndrom
iri
affect
cn
littl
known
traffick
cell
cn
interact
glycoprotein
contribut
recruit
human
cell
brain
vessel
migrat
affect
block
interact
previous
shown
partak
recruit
immun
cell
popul
cn
conflict
result
neutral
eae
enceph
restrict
infiltr
cn
suggest
cell
may
use
altern
possibl
unidentifi
adhes
molecul
gain
access
cn
rais
potenti
select
control
traffick
brain
use
murin
model
cn
autoimmun
aim
studi
defin
role
migrat
across
bbb
neuroinflamm
specifi
heterodim
contain
subunit
name
implic
mice
select
express
haemagglutinin
ha
influenza
viru
neuron
control
calmodulin
kinas
promot
mice
control
litterm
exhibit
sever
encephalomyel
character
weight
loss
neurolog
sign
death
recipi
adopt
transfer
vitro
gener
cytotox
cell
diabet
insipidu
caus
destruct
hypothalam
neuron
promin
clinic
manifest
surviv
recipi
endogen
cell
also
infiltr
cn
mice
develop
encephalomyel
support
inform
fig
howev
recipi
underw
weight
loss
diabet
insipidu
endogen
cell
requir
diseas
develop
support
inform
fig
delin
model
role
migrat
cn
first
show
vitro
differenti
cytotox
cell
express
subunit
heterodim
fig
mab
heterodim
use
vitro
bind
assay
indirectli
show
vitro
differenti
cytotox
cell
express
heterodim
cell
untreat
treat
control
igg
bind
recombin
mab
complet
inhibit
bind
anova
p
affect
bind
fig
main
ligand
heterodim
suggest
cell
express
function
heterodim
assess
whether
treatment
mice
mab
could
protect
encephalomyel
therefor
treat
recipi
control
igg
day
adopt
transfer
cytotox
cell
compar
recipi
receiv
control
igg
recipi
treat
mab
lost
less
weight
anova
p
show
death
versu
test
p
addit
survivor
experienc
less
diabet
insipidu
versu
fig
sinc
subunit
share
heterodim
investig
one
involv
migrat
cn
current
mab
avail
specif
recogn
heterodim
mab
recogn
block
specif
heterodim
therefor
treat
recipi
mab
recipi
underw
clinic
phenotyp
mice
receiv
control
mab
indirectli
strongli
suggest
essenti
heterodim
activ
migrat
cn
model
howev
blockad
fulli
abrog
neurolog
sign
induc
transfer
mice
signific
weight
loss
develop
compar
control
litterm
fig
central
diabet
insipidu
detect
treat
recipi
next
investig
impact
blockad
cn
inflammatori
infiltr
composit
tissu
damag
eight
day
adopt
transfer
cytotox
cell
recipi
treat
mab
control
igg
sacrif
cell
analyz
flow
cytometri
drastic
reduct
number
cell
infiltr
cn
observ
recipi
treat
mab
versu
cellscn
respect
test
p
fig
ex
vivo
analysi
splenocyt
show
mab
deplet
cell
peripheri
even
promot
accumul
transfer
cell
secondari
lymphoid
organ
support
inform
fig
moreov
ex
vivo
analys
restimul
cognat
ha
peptid
show
mab
also
affect
activ
transfer
cell
collect
spleen
lymph
node
support
inform
fig
cn
observ
decreas
microgli
activ
evalu
mhc
class
ii
express
cell
recipi
treat
mab
mfi
mhc
class
ii
versu
test
p
fig
histolog
analysi
also
corrobor
mark
reduct
parenchym
infiltr
recipi
treat
anim
test
p
fig
mening
cell
could
still
detect
antagon
therefor
inhibit
infiltr
microgli
activ
cn
parenchyma
recipi
mice
investig
contribut
cell
traffick
cn
investig
ligand
express
brain
microvascular
endotheli
cell
may
interact
first
block
vivo
major
ligand
use
two
distinct
mab
mab
provid
ident
result
fig
two
group
pool
figur
c
recipi
treat
mab
lost
weight
anova
p
develop
diabet
insipidu
frequent
versu
test
yate
correct
p
compar
mice
treat
mab
fig
clinic
outcom
weight
loss
diabet
insipidu
death
significantli
differ
recipi
mice
treat
mab
control
igg
assess
impact
inhibit
infiltr
cn
unambigu
identifi
enumer
transfer
cell
cell
inject
mice
fig
flow
cytometri
analysi
cell
recipi
day
adopt
transfer
reveal
signific
reduct
number
transfer
cell
mice
treat
mab
compar
mice
receiv
control
igg
versu
cell
test
p
fig
howev
blockad
reduc
number
transfer
cell
much
lesser
extent
use
mab
cell
test
p
collect
data
indic
blockad
partial
inhibit
migrat
cell
across
bbb
protect
mice
develop
cn
tissu
damag
suggest
addit
vascular
ligand
might
implic
cell
traffick
cn
junction
adhes
report
ligand
endotheli
cell
assess
contribut
anoth
put
bbb
endotheli
ligand
migrat
cn
inde
cn
microvascular
endotheli
cell
express
addit
fig
investig
whether
could
potenti
ligand
express
cell
treat
recipi
mab
day
adopt
transfer
cytotox
cell
recipi
treat
mab
display
significantli
less
weight
loss
compar
recipi
treat
control
igg
mab
display
incid
diabet
insipidu
death
fig
flow
cytometri
analysi
cn
recipi
treat
mab
show
signific
decreas
number
infiltr
transfer
cell
compar
mice
receiv
control
igg
versu
cellscn
test
p
fig
decreas
similar
achiev
block
test
ns
clearli
inferior
inhibit
achiev
mab
test
p
fig
increas
dose
mab
improv
reduct
transfer
cell
suggest
satur
concentr
antibodi
obtain
support
inform
fig
therefor
express
bbb
endotheli
cell
might
repres
ligand
migrat
cell
cn
order
test
hypothesi
complementari
ligand
treat
recipi
mab
coadministr
mab
demonstr
synergist
reduct
number
transfer
cell
fig
final
investig
phenotyp
cell
enter
cn
recipi
blockad
wherea
absolut
number
differ
importantli
group
proport
transfer
cell
produc
significantli
differ
group
fig
molecular
cue
use
cell
migrat
cn
poorli
defin
use
murin
model
cn
autoimmun
neuroinflamm
show
migrat
cytotox
cell
cn
reli
heterodim
also
show
express
bbb
endotheli
cell
like
implic
process
inhibit
insuffici
complet
block
infiltr
cn
mitig
clinic
encephalomyel
sign
two
studi
use
anim
model
neuroinflamm
vitro
transmigr
assay
demonstr
block
decreas
migrat
cell
across
cn
vascular
structur
howev
common
heterodim
unknown
one
implic
model
show
blockad
heterodim
prevent
encephalomyel
tissu
damag
interf
cytotox
entri
cn
result
strongli
suggest
essenti
heterodim
interact
activ
cell
bbb
similarli
block
abrog
develop
eae
mediat
encephalitogen
cell
cell
critic
reli
accumul
cn
eae
moreov
block
heterodim
fail
inhibit
eae
develop
mice
rhesu
monkey
ectop
express
ligand
cn
endotheli
cell
fail
trigger
cn
recruit
cell
thu
rather
mediat
interact
cn
endothelium
howev
blockad
total
abrog
clinic
sign
cn
infiltr
transfer
cell
model
rout
although
accessori
remain
oper
molecular
base
still
determin
studi
brain
endotheli
ligand
constitut
express
low
level
bbb
endothelium
mediat
initi
captur
subsequ
arrest
cell
upon
interact
express
upregul
inflammatori
condit
endotheli
cell
bbb
barrier
well
choroid
plexu
epithelium
fluid
barrier
increas
adhes
inflam
cn
endothelium
previous
shown
blockad
inhibit
clinic
histopatholog
sign
eae
mediat
encephalitogen
cell
model
listeria
monocytogen
infect
access
cell
cn
inhibit
blockad
extent
blockad
unexpectedli
blockad
model
partial
effect
migrat
cn
number
cell
reduc
compar
mice
treat
control
igg
fig
decreas
clinic
relev
recipi
treat
differ
clone
mab
experienc
weight
loss
death
diabet
insipidu
extent
mice
treat
control
igg
therefor
blockad
suffici
model
inhibit
migrat
cn
sever
differ
studi
young
et
al
might
explain
discord
result
includ
genet
background
mice
balbc
balbc
versu
local
ha
ova
antigen
differ
cell
neuron
oligodendrocyt
respect
state
differenti
encephalitogen
cell
termin
differenti
highli
cytotox
versu
shortli
activ
cell
moreov
l
monocytogen
infect
within
cn
model
might
induc
addit
trigger
includ
increas
express
bbb
allow
increas
migrat
cn
suggest
natalizumab
human
mab
human
subunit
might
also
affect
express
molecul
treat
natalizumab
patient
use
short
treatment
addit
high
specif
murin
subunit
make
antibodi
unlik
integrin
subunit
unrel
molecul
selectin
inde
recogn
function
epitop
subunit
shown
specif
block
lymphocyt
bind
fibronectin
well
bind
vitro
anoth
explan
could
model
sole
even
main
ligand
respect
investig
known
ligand
might
implic
least
two
addit
vascular
ligand
describ
domain
splice
variant
fibronectin
sinc
reliabl
block
antibodi
domain
current
avail
role
fibronectin
migrat
process
cell
could
explor
yet
interact
investig
vitro
vivo
skin
microvasculatur
express
bbb
model
focus
put
ligand
migrat
cn
member
classic
jam
famili
transmembran
type
protein
two
immunoglobulin
domain
highli
express
cell
present
well
organ
tight
junction
endothelium
bbb
interact
implic
cell
migrat
cn
block
mab
direct
significantli
inhibit
leukocyt
infiltr
csf
brain
parenchyma
model
mening
howev
result
confirm
infecti
mening
play
central
role
regul
paracellular
permeabl
also
impact
roll
firm
adhes
although
lack
express
steadi
state
brain
endotheli
cell
suggest
show
express
brain
endotheli
cell
murin
model
cn
autoimmun
blockad
associ
partial
protect
encephalomyel
signific
reduct
number
infiltr
cell
howev
lesser
extent
blockad
data
suggest
particip
migrat
process
cn
discoveri
role
interact
migrat
cn
led
develop
natalizumab
proven
highli
benefici
ms
unfortun
natalizumab
associ
increas
risk
develop
progress
multifoc
leukoencephalopathi
pml
opportunist
diseas
cn
caus
john
cunningham
jc
viru
infect
oligodendrocyt
develop
pml
follow
natalizumab
therapi
like
reli
multifactori
scenario
includ
permiss
activ
jc
viru
replic
impair
immun
surveil
compar
untreat
ms
patient
natalizumab
treatment
induc
decreas
cerebrospin
fluid
cell
cell
crucial
control
jc
viru
reactiv
dissemin
result
suggest
develop
pml
least
part
due
inhibit
cn
immunosurveil
jc
cell
furthermor
pml
ms
patient
often
complic
natalizumab
withdraw
iri
darken
prognosi
although
cell
might
particip
clear
domin
cell
observ
occur
patient
ms
reminisc
patholog
describ
patient
indirectli
support
idea
discontinu
natalizumab
allow
migrat
cell
cn
migrat
encephalitogen
cell
cn
depend
blockad
ms
benefici
expos
opportunist
viral
infect
due
disrupt
cn
immun
surveil
cell
requir
cn
migrat
distinct
immun
cell
futur
work
help
identifi
novel
molecular
target
block
specif
cn
recruit
destruct
immun
cell
leav
migrat
protect
immun
cell
subset
cn
unaffect
transgen
mous
line
express
tcr
influenza
viru
ha
transmembran
peptid
amino
acid
iystvassl
ha
mice
describ
previous
mice
obtain
cross
transgen
mice
ha
mice
genom
dna
recombin
result
transcript
ha
occur
mice
confin
brain
spinal
cord
mice
backcross
least
six
time
balbc
background
experi
benefit
congen
marker
allow
distinct
transfer
cell
recipi
cell
donor
recipi
mice
balbc
background
use
note
number
cell
infiltr
cn
mice
differ
balbc
balbc
background
support
inform
fig
mice
onset
experi
mice
kept
specif
condit
studi
carri
strict
accord
eu
regul
recommend
french
nation
chart
ethic
anim
experi
articl
r
code
rural
protocol
approv
committe
ethic
anim
experi
permit
number
procedur
perform
deep
anesthesia
describ
effort
made
minim
anim
suffer
cytotox
cell
gener
previous
describ
briefli
purifi
naiv
cell
mice
stimul
irradi
syngen
splenocyt
dmem
supplement
fc
life
technolog
paisley
scotland
contain
mm
ha
peptid
ngml
ngml
day
cell
collect
ficol
densiti
separ
live
cytotox
cell
inject
intraven
recipi
mice
cell
routin
contain
cell
produc
high
level
granzym
b
mab
inject
intraven
rat
mab
mous
clone
clone
clone
antiendoglin
control
igg
clone
produc
lab
rat
mab
clone
produc
rl
lab
clone
clone
indic
purchas
ebiosci
r
system
respect
mice
deepli
anesthet
perfus
ml
pb
purif
mononuclear
cell
brain
collect
pb
dissoci
use
glass
potter
brain
suspens
enzymat
digest
h
rpmi
medium
invitrogen
contain
collagenas
mgml
dnase
mgml
digest
suspens
filter
mm
cell
strainer
falcon
mononuclear
cell
collect
percol
densiti
separ
directli
use
fac
stain
purif
mononuclear
cell
spleen
cervic
drain
lymph
node
organ
collect
pb
dissoci
use
glass
potter
red
blood
cell
lysi
mononuclear
cell
use
fac
stain
mononuclear
cell
spleen
cervic
lymph
node
plate
plate
h
restimul
ha
peptid
noncogn
antigen
peptid
rylkngketl
bd
pharmingen
ad
last
h
mononuclear
cell
use
fac
stain
vitro
differenti
cytotox
cell
stain
use
viabil
dye
bd
pharmingen
hybridoma
supernat
clone
hybridoma
supernat
clone
heterodim
hybridoma
supernat
clone
mononuclear
cell
stain
use
viabil
dye
bd
pharmingen
biolegend
bd
pharmingen
ebiosci
ebiosci
bd
pharmingen
bd
pharmingen
class
ii
ebiosci
biolegend
bd
pharmingen
bd
pharmingen
mab
fixat
permeabil
cell
intracellularli
stain
bd
bioscienc
bd
pharmingen
data
collect
lsrii
facscalibur
becton
dickinson
analyz
flowjo
softwar
tree
star
well
diagnost
microscop
slide
thermo
scientif
coat
protein
pb
ph
h
protein
incub
well
wash
three
time
pb
ph
block
bsa
pb
min
subsequ
well
wash
pb
ph
recombin
protein
nm
incub
h
recombin
chimera
r
recombin
mous
chimera
r
recombin
chimera
r
recombin
well
wash
twice
pb
ph
block
bsa
pb
min
room
temperatur
perform
vitro
bind
assay
cytotox
cell
collect
cellsml
assay
medium
dmem
mm
hepe
calf
serum
incub
either
block
antibodi
isotyp
control
antibodi
rat
min
room
temperatur
antibodi
wash
away
centrifug
min
rpm
diagnost
microscop
slide
place
rotat
platform
cell
suspens
cellswel
ad
incub
recombin
protein
min
slide
wash
twice
pb
fix
vv
glutaraldehyd
pb
number
adher
cell
evalu
count
bound
cell
per
field
view
microscop
use
grid
ocular
prepar
mous
tissu
stain
procedur
perform
publish
previous
briefli
mice
perfus
pb
formaldehyd
pb
left
ventricl
heart
dissect
tissu
embed
sakura
netherland
frozen
store
immunofluoresc
stain
cryostat
section
fix
methanol
follow
block
block
buffer
bsa
fc
donkey
serum
pb
subsequ
primari
rabbit
antibodi
kindli
provid
beat
imhof
geneva
switzerland
either
rat
antimous
mec
rat
antimous
incub
section
h
antibodi
incub
section
wash
pb
section
incub
secondari
antibodi
goat
antirat
alexa
invitrogen
mp
donkey
antirabbit
jir
dapi
invitrogen
h
coverslip
mowiol
usa
immunofluoresc
stain
cryostat
section
fix
ethanol
min
follow
aceton
min
room
temperatur
subsequ
section
dri
min
room
temperatur
block
solut
skim
milk
tb
incub
min
primari
antibodi
lyt
ebiosci
secondari
antibodi
ebiosci
dilut
block
solut
antibodi
incub
perform
h
room
temperatur
visual
cell
nuclei
dapi
invitrogen
incub
min
room
temperatur
section
wash
tb
incub
step
final
mount
mowiol
analyz
use
nikon
eclips
fluoresc
microscop
differ
two
set
data
evalu
u
test
analysi
scatter
plot
compar
group
mice
anova
bonferroni
posttest
use
surviv
curv
plot
method
compar
test
data
repres
mean
sem
probabl
valu
p
consid
statist
signific
test
carri
use
graphpad
prism
graphpad
softwar
la
jolla
ca
usa
author
declar
financi
commerci
conflict
interest
